Compound information
- Natural Products
- ZC1332384
- Molecular Formula
- C12H16O2S
- Molecular Weight
- 224.087100752 g/mol
- Structure
-
- IUPAC Name
- 5-(2-methoxyphenyl)sulfanylpentan-2-one
- InChI
- InChI=1S/C12H16O2S/c1-10(13)6-5-9-15-12-8-4-3-7-11(12)14-2/h3-4,7-8H,5-6,9H2,1-2H3
- InChI Key
- SFHLLNFPMXSXSA-UHFFFAOYSA-N
- SMILES
- COc1ccccc1SCCCC(C)=O
- Source
- ZINC000041031037
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 15 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 26.3 Å2 | LogP | 2.247 |
LogS | -2.493 | LogD | 2.488 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.838 | Pgp substrate | 0.008 |
HIA | 0.962 | F20 % | 0.989 |
F30 % | 0.564 | Caco-2 | -4.339 |
MDCK | -4.403 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.986 | PPB | 71.285 |
VD | 2.242 | Fu | 1.256 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 1.0 | CYP1A2 substrate | 0.382 |
CYP2A6 substrate | 0.676 | CYP2B6 substrate | 0.694 |
CYP2C19 inhibitor | 0.668 | CYP2C19 substrate | 0.802 |
CYP2C8 substrate | 0.663 | CYP2C9 inhibitor | 0.062 |
CYP2C9 substrate | 0.946 | CYP2D6 inhibitor | 0.067 |
CYP2D6 substrate | 0.758 | CYP2E1 substrate | 0.547 |
CYP3A4 inhibitor | 0.062 | CYP3A4 substrate | 0.322 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.85 | CL | 9.303 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.034 | Hepatotoxicity | 0.928 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.04 |
FDAMDD | 0.105 | Skin Sensitization | 0.839 |
Carcinogenicity | 0.575 | Eye Corrosion | 0.003 |
Eye Irritation | 0.82 | Respiratory Toxicity | 0.344 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.928 | IGC50 | 2.89 |
LC50FM | 4.09 | LC50DM | 4.025 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.118 | NR-AR-LBD | 0.221 |
NR-AhR | 0.061 | NR-Aromatase | 0.051 |
NR-ER | 0.327 | NR-ER-LBD | 0.263 |
NR-PPAR-gamma | 0.288 | SR-ARE | 0.052 |
SR-ATAD5 | 0.457 | SR-HSE | 0.107 |
SR-MMP | 0.042 | SR-p53 | 0.09 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.